Jiang Y - Search Results

1

INO80 chromatin remodeling complex promotes the removal of UV lesions by the nucleotide excision repair pathway.

Jiang Y, Wang X, Bao S, Guo R, Johnson DG, Shen X, Li L. Jiang Y, et al. Proc Natl Acad Sci U S A. 2010 Oct 5;107(40):17274-9. doi: 10.1073/pnas.1008388107. Epub 2010 Sep 20. Proc Natl Acad Sci U S A. 2010. PMID: 20855601 Free PMC article.

2

FANCM and FAAP24 maintain genome stability via cooperative as well as unique functions.

Wang Y, Leung JW, Jiang Y, Lowery MG, Do H, Vasquez KM, Chen J, Wang W, Li L. Wang Y, et al. Among authors: jiang y. Mol Cell. 2013 Mar 7;49(5):997-1009. doi: 10.1016/j.molcel.2012.12.010. Epub 2013 Jan 17. Mol Cell. 2013. PMID: 23333308 Free PMC article.

3

Repair of DNA damage induced by the novel nucleoside analogue CNDAG through homologous recombination.

Liu X, Jiang Y, Nowak B, Ichikawa S, Ohtawa M, Matsuda A, Plunkett W. Liu X, et al. Among authors: jiang y. Cancer Chemother Pharmacol. 2020 Apr;85(4):661-672. doi: 10.1007/s00280-020-04035-x. Epub 2020 Feb 18. Cancer Chemother Pharmacol. 2020. PMID: 32072218

4

Molecular basis for G2 arrest induced by 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine and consequences of checkpoint abrogation.

Liu X, Guo Y, Li Y, Jiang Y, Chubb S, Azuma A, Huang P, Matsuda A, Hittelman W, Plunkett W. Liu X, et al. Among authors: jiang y. Cancer Res. 2005 Aug 1;65(15):6874-81. doi: 10.1158/0008-5472.CAN-05-0288. Cancer Res. 2005. PMID: 16061671

5

CNDAC-Induced DNA Double-Strand Breaks Cause Aberrant Mitosis Prior to Cell Death.

Liu X, Jiang Y, Takata KI, Nowak B, Liu C, Wood RD, Hittelman WN, Plunkett W. Liu X, et al. Among authors: jiang y. Mol Cancer Ther. 2019 Dec;18(12):2283-2295. doi: 10.1158/1535-7163.MCT-18-1380. Epub 2019 Sep 9. Mol Cancer Ther. 2019. PMID: 31501277 Free PMC article.

6

DNA-dependent protein kinase and ataxia telangiectasia mutated (ATM) promote cell survival in response to NK314, a topoisomerase IIα inhibitor.

Guo L, Liu X, Jiang Y, Nishikawa K, Plunkett W. Guo L, et al. Among authors: jiang y. Mol Pharmacol. 2011 Aug;80(2):321-7. doi: 10.1124/mol.109.057125. Epub 2011 May 5. Mol Pharmacol. 2011. PMID: 21546556 Free PMC article.

7

Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia.

Chen R, Guo L, Chen Y, Jiang Y, Wierda WG, Plunkett W. Chen R, et al. Among authors: jiang y. Blood. 2011 Jan 6;117(1):156-64. doi: 10.1182/blood-2010-01-262808. Epub 2010 Oct 22. Blood. 2011. PMID: 20971952 Free PMC article.

8

Targeting BRCA1/2 deficient ovarian cancer with CNDAC-based drug combinations.

Liu X, Jiang Y, Nowak B, Qiang B, Cheng N, Chen Y, Plunkett W. Liu X, et al. Among authors: jiang y. Cancer Chemother Pharmacol. 2018 Feb;81(2):255-267. doi: 10.1007/s00280-017-3483-6. Epub 2017 Nov 30. Cancer Chemother Pharmacol. 2018. PMID: 29189915 Free PMC article.

9

Mechanism-Based Drug Combinations with the DNA Strand-Breaking Nucleoside Analog CNDAC.

Liu X, Jiang Y, Nowak B, Hargis S, Plunkett W. Liu X, et al. Among authors: jiang y. Mol Cancer Ther. 2016 Oct;15(10):2302-2313. doi: 10.1158/1535-7163.MCT-15-0801. Epub 2016 Jul 29. Mol Cancer Ther. 2016. PMID: 27474148 Free PMC article.

10

Dual-channel bistability modulation in a bilayer graphene-based optomechanical system.

Jiang Y, Wang X, Peng Y, Long L, Zhao W, Li J. Jiang Y, et al. Opt Lett. 2024 Nov 1;49(21):6093-6096. doi: 10.1364/OL.530823. Opt Lett. 2024. PMID: 39485431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43,780 results

Search Page

Filters